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Subacute sclerosing
panencephalitis presenting as
rapidly progressive dementia in
a  young adult
Demencia rápidamente progresiva  en adulto
joven como forma  de presentación  de
panencefalitis esclerosante subaguda
Dear  Editor:
Subacute  sclerosing  panencephalitis  (SSP)  is  a  neurodegen-
erative  disorder  caused  by  persistent  infection  with  measles
virus.1 It is  characterised  by  progressive  cognitive  and  motor
impairment  and  associated  with  myoclonus.1,2 The  condition
is  rarely  observed  in adult  patients;  when  this  does  occur,
SSP  manifests  with  atypical  symptoms.3
We  present  the  case  of  a 25-year-old  man with  no  rele-
vant  medical  history  who  developed  behavioural  alterations
Figure  1  (1a  and  1b)  Axial  FLAIR  MR  images  (12  months  after  symptom  onset)  showing  diffuse  hyperintensities  in cortical  and
subcortical  regions  of the  parietal  and  temporal  lobes.  (2a/b,  3a/b)  Axial  FLAIR  MR  images  (26  months  and  8  years  after  symptom
onset, respectively)  revealing  disease  progression,  with  severe  cerebellar  and  brainstem  atrophy  and a  diffuse,  extensive  lesion  to
the periventricular  white  matter.
 Please cite this article as: Martins R, Peres J, Casimiro C,
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and  cognitive  deficits  over  the  course  of  3  years  due  to
SSP.  The  initial  neurological  examination  revealed  inatten-
tion,  impaired  executive  function,  poor  language  fluency,
motor  perseveration,  predominantly  right-sided  ideomotor
apraxia,  asomatognosia,  agraphaesthesia,  and  right  hemi-
paresis.  A  brain  MRI scan  revealed  an extensive  left-sided
cortico-subcortical  temporoparietal  lesion,  as  well  as  other
smaller  lesions  in the  bilateral  subcortical  white  matter  on
T2-weighted  and  FLAIR  sequences;  lesions  showed  no  con-
trast  uptake  and the  results  of a  cerebral  angiography  study
were  normal  (Fig.  1: 1a  and 1b).  Serial  electroencephalogra-
phy  revealed  diffuse  slowing,  with  theta  rhythm  in  posterior
regions  and  no  periodic  activity.
We excluded  prion  disease,  autoimmune  encephalopathy,
inflammatory  vasculopathy,  and  progressive  multifocal
leukoencephalopathy.  The  results  from  serology  tests and
autoimmune  studies  were  negative.  A lumbar  puncture
yielded  the  following  results:  one red  blood  cell,  51  mg/dL
glucose,  54  mg/dL  proteins,  and a  high  IgG index  (1.74)  with
presence  of  oligoclonal  bands.  Results  from  CSF polymerase
chain  reaction  for  Tropheryma  whippelii  and herpes  sim-
plex,  varicella-zoster,  and  JC  viruses;  syphilis  serology;  and
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14-3-3  protein  determination  were  all  negative.  Radiologi-
cal  studies  and  CSF anti-neuronal  antibody  determinations
revealed  no tumours.
The  clinical,  imaging,  and  laboratory  findings  led to
suspicion  of  SSP;  diagnosis  was  confirmed  by  high  anti-
measles  virus  antibody  titres  in the serum  and CSF (1:10
and  1:134,  respectively).  The  patient  had  no  history  of
infection  or  exposure  to  measles  virus  and  had  been  vac-
cinated  against  the  virus.  In the following  6  months,  the
patient’s  clinical  symptoms  worsened  progressively:  he dis-
played  myoclonus  in the  form of  periodic  supraversion  eye
movements  and  refractory  tonic-clonic  seizures.  A  follow-up
MRI  scan  revealed  severe  cerebellar  and  brainstem  atrophy
(Fig.  1: 2a,  2b,  3a, and  3b). The  patient  is  currently  in a
vegetative  state,  displaying  akinetic  mutism.
SSP  typically  presents  during  the  first  and  second  decades
of  life;  only  100 cases of  adult-onset  SSP  are described  in
the  literature.4 Incidence  of  the  condition  decreased  by  90%
after  the  introduction  of the measles  vaccine  into  the vac-
cination  schedule.5 A causal relationship  between  measles
vaccination  and  SSP  has  not been  determined.  The  cases  of
SSP  described  in patients  vaccinated  against  measles  virus
are  thought  to  be  due  to subclinical  measles  infection  within
the  first  year  of  life.1
As  in  our  case,  most  cases of  adult-onset  SSP  are not  asso-
ciated  with  a  history  of  infection  or  exposure  to  measles
virus.3 Atypical  symptoms  are  also  more  frequent  in  adult-
onset  SSP.2,3 Our  patient  experienced  progressive  motor
and  cognitive  impairment  without  generalised  myoclonus  or
periodic  EEG  activity;  these  findings  are  typical  in  advanced
stages  of  the  disease.3 High anti-measles  virus  antibody
titres  in the  serum  and  CSF  confirm  the diagnosis  of  SSP
due  to  their  high  sensitivity,  specificity,  and  positive  predic-
tive  value.1,2 Death  usually  occurs  1-3  years  after  symptom
onset;  there  is  currently  no  effective  treatment  for  the
condition.2 A combination  of  intrathecal  interferon  alfa and
oral  isoprinosine  has  shown  an efficacy  of  30%  to  35%  in clin-
ical  trials.6,7 Our  patient  did  not  start treatment  due  to  the
advanced  stage  of the  condition.
In conclusion,  a  diagnosis  of SSP  must  be  considered
in  young  patients  with  progressive  cognitive  impairment.
Atypical  symptoms  are frequent  in adult-onset  SSP,  espe-
cially  in cases with  compatible  serology  and imaging
findings.
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Locating the site of
cerebrospinal fluid leak in a
patient  with low cerebrospinal
fluid  pressure
Localización del punto  de  fuga de líquido
cefalorraquídeo en  un  caso de hipotensión de
líquido cefalorraquídeo
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Padilla Parrado F, Aguilar Cuevas R.  Localización del punto de fuga
de líquido cefalorraquídeo en un caso de hipotensión de líquido
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Dear  Editor:
Low  cerebrospinal  fluid  (CSF) pressure  due  to  meningeal  tear
is  an infrequent  but  widely  reported  condition,  often  associ-
ated  with  typical  neuroimaging  findings  that  are  helpful  for
diagnosis.  However,  it is  relatively  infrequent  for  the  site of
the  CSF  leak to  be located,  especially  in cases  secondary  to
mild  trauma;  the upper  thoracic  spine  and cervico-thoracic
junction  are the  most  frequent  locations.1 Locating  the site
of the CSF leak  is  relevant  due  to  the possible  prognostic
implications.
We  present  a case  with  striking  neuroimaging  findings,
which  enabled  us to clearly  locate the site  of  the  CSF  leak
at  the  lumbar  level  (a  rare  location);  this was  essential  to
establish  a  definitive  treatment.
Our  patient  was  a 30-year  old  woman  with  no  rele-
vant  personal  history,  who  visited  our  department  due  to
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